107 related articles for article (PubMed ID: 1976210)
1. Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase.
Liebow C; Lee MT; Schally A
Metabolism; 1990 Sep; 39(9 Suppl 2):163-6. PubMed ID: 1976210
[No Abstract] [Full Text] [Related]
2. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.
Lee MT; Liebow C; Kamer AR; Schally AV
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1656-60. PubMed ID: 1672042
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
Liebow C; Reilly C; Serrano M; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
[TBL] [Abstract][Full Text] [Related]
5. The tumor-selective somatostatin analog, TT2-32 induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620.
Vántus T; Csermely P; Teplán I; Kéri G
Tumour Biol; 1995; 16(4):261-7. PubMed ID: 7604207
[TBL] [Abstract][Full Text] [Related]
6. Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin.
Lee LT; Schally AV; Liebow C; Lee PP; Lee PH; Lee MT
Anticancer Res; 2008; 28(5A):2599-605. PubMed ID: 19035284
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
8. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line.
Hierowski MT; Liebow C; du Sapin K; Schally AV
FEBS Lett; 1985 Jan; 179(2):252-6. PubMed ID: 2857131
[TBL] [Abstract][Full Text] [Related]
9. Novel antitumor peptide hormones and their effect on signal transduction.
Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
Kawase T; Orikasa M; Ogata S; Burns DM
Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and GH-inhibitory activity of chimeric peptides consisting of GHRP-6 and somatostatin.
Dasgupta P; Singh AT; Mukherjee R
Biochem Biophys Res Commun; 1999 Jun; 259(2):379-84. PubMed ID: 10362518
[TBL] [Abstract][Full Text] [Related]
14. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
15. Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells.
Chajry N; Martin PM; Cochet C; Berthois Y
Eur J Biochem; 1996 Jan; 235(1-2):97-102. PubMed ID: 8631373
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
17. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
Greulich H; Reichman C; Hanafusa H
Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line.
Kéri G; Balogh A; Szöke B; Teplán I; Csuka O
Tumour Biol; 1991; 12(2):61-7. PubMed ID: 1902971
[TBL] [Abstract][Full Text] [Related]
19. The insulin receptor and tyrosine protein kinase activity.
Cobb MH; Rosen OM
Biochim Biophys Acta; 1984; 738(1-2):1-8. PubMed ID: 6331499
[No Abstract] [Full Text] [Related]
20. Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells.
Payrastre B; Plantavid M; Breton M; Chambaz E; Chap H
Biochem J; 1990 Dec; 272(3):665-70. PubMed ID: 2176471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
